Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV. (Q51781234)
Jump to navigation
Jump to search
scientific article published on 10 October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV. |
scientific article published on 10 October 2006 |
Statements
1 reference
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV. (English)
1 reference
Gerald Friedland
1 reference
Saye Khoo
1 reference
Christopher Jack
1 reference
Umesh Lalloo
1 reference
10 October 2006
1 reference
58
1 reference
6
1 reference
1299-1302
1 reference
Identifiers
1 reference
1 reference